The ECM as a Spatial Organizer of

Slides:



Advertisements
Similar presentations
Cell Communication Cells need to communicate with one another, whether they are located close to each other or far apart. Extracellular signaling molecules.
Advertisements

Angiogenesis.
Biology Developmental Genetics
Coordination of cellular-fate processes
Cell Differentiation: Cell interactions in Development
Interactions Between Cells and Their Environment
The Extracellular Matrix Michael Malahy. ECM in Epithelial Sheets 3 types of molecules abundant in ECM Proteoglycans Cushion cells and bind extracellular.
Tissue Repair Dr. Raid Jastania. What is Repair? When does regeneration occur? When does fibrosis occur? What are the consequences of fibrosis?
MBBS Cancer Biology Module 2006 Tumour Vasculature and Therapeutic Strategies Barbara Pedley.
วัตถุประสงค์ สามารถอธิบายขั้นตอนการสร้างหลอดเลือดพร้อมทั้งบอก บทบาทของโปรตีนที่เกี่ยวข้องได้ สามารถอธิบายขั้นตอนการสร้างหลอดเลือดพร้อมทั้งบอก บทบาทของโปรตีนที่เกี่ยวข้องได้
Angiogenesis ↓ Metastasis. Angiogenesis--- The process of developing new blood vessels. Cancer cells (probably like all tissues) secrete substances that.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Blood Vessels and Nerves Common Signals, Pathways and Diseases.
Development and Genes Part 1. 2 Development is the process of timed genetic controlled changes that occurs in an organism’s life cycle. Mitosis Cell differentiation.
Vasculogenesis and angiogenesis Integrins in vasculature and KO phenotypes Growth Factor Receptors signaling and vasculature phenotypes VEGFR Tip cells.
Fibroblast Growth Factors (FGFs)
TUMOR ANGIOGENESIS. Formation of new blood vessels is called angiogenesis Tumor angiogenesis is the proliferation of a network of blood vessels that penetrates.
Date of download: 6/3/2016 Copyright © American College of Chest Physicians. All rights reserved. Tissue Factor, Thrombin, and Cancer * Chest. 2003;124(3_suppl):58S-68S.
The Role of Cell Adhesion in Inflammation and Metastasis 赵燃 丁合
Chapter 11 Cell Communication.
Figure 2 Dicer and RISC (RNA-induced silencing complex).
Abstract PI3K–Akt signaling is critical for the development, progression, and metastasis of malignant tumors, but its role in the tumor microenvironment.
Trans. Vis. Sci. Tech ;5(2):10. doi: /tvst Figure Legend:
Integrin signalling Vytášek 2010.
ANIMAL CELL CULTURE.
Arne R. M. van der Bilt, Elisabeth G. E
Angiogenesis and hepatocellular carcinoma
Inducing Angiogenesis
Cell Communication.
CD146: a new partner for VEGFR2
Chemokines A class of proteins secreted by cells which functions to attract cells.
Tissue repair (3&4 of 4) Ali Al Khader, M.D. Faculty of Medicine
Inducing Angiogenesis
Activating Invasion and Metastasis
Activating Invasion and Metastasis
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is increased in osteoarthritis and regulates chondrocyte catabolic and anabolic activities 
Figure 1 Pre-eclampsia prevents VEGF signalling in endothelial cells
VEGF-D: a modifier of embryonic lymphangiogenesis
Types of Tumor Vascularization
HOMING
Integrin signalling Vytášek 2009.
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Xiaolan Yao, Samuel Bouyain  Structure 
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
Stealing VEGF from Thy Neighbor
Macrophages and Therapeutic Resistance in Cancer
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
Endocrinology Introduction Lecture 3.
Macrophages and Therapeutic Resistance in Cancer
Won't You Be My Neighbor? Local Induction of Arteriogenesis
Angiogenesis and hepatocellular carcinoma
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Vascular Endothelial Growth Factor (VEGF) Pathway
FGFR Signaling as a Target for Lung Cancer Therapy
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
Figure 1 The VEGF family of growth factors
The Role of Apolipoprotein E in Alzheimer's Disease
Vascular frontiers without borders
VEGF-B Improves Metabolic Health through Vascular Pruning of Fat
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
Angiogenesis: A Team Effort Coordinated by Notch
Vascular Endothelial Growth Factor and Epidermal Growth Factor Signaling Pathways as Therapeutic Targets for Colorectal Cancer  Thomas Winder, Heinz–Josef.
Process and mechanisms of blood vessel formation.
Passing the baton: the HIF switch
Kristy Red-Horse, Yongping Crawford, Farbod Shojaei, Napoleone Ferrara 
Endothelial Cells Form a Phalanx to Block Tumor Metastasis
Fibronectin at Select Sites Binds Multiple Growth Factors and Enhances their Activity: Expansion of the Collaborative ECM-GF Paradigm  Jia Zhu, Richard.
Model of the Ang-1 pathway in early lung development.
UPR and cross-talk between apoptosis and metabolism.
Vascular frontiers without borders
Presentation transcript:

The ECM as a Spatial Organizer of Growth Factors Chris Liu 8/21/03

What happens when growth factors are secreted/released extracellular?

What is a Morphogen? Long-range signalling molecule Acts directly on cells (Wolpert, 1969)

Different models of Morphogen Action Morphogen Diffusion Morphogen inhibitor diffusion Cytoneme function Close physical interaction Cytoplasmic diffusion.

Along limb buds, can see morphogen gradients. These factors may be dependent upon: morphogen transport morphogen stability

There is also a lot of regulation of morphogen receptors. Are there other factors?

Heparin Sulfate Proteoglycan (HSPGs) localize many morphogens. Some representative HSPGs These are characterized as “cofactors” for signalling. Through genetic studies, they modify the phenotypes GFs and GFRs Heparin synthesis genes have also been implicated.

VEGF exists in different isoforms heparin binding rare common none 50-70% total

VEGF exists in different isoforms rare common Releases soluble VEGF

Cellular Receptors for VEGF There appears to be synergy between NRP1 and VEGFR-2

VEGF-A (through KO studies) is essential for : embryonic blood vessel formation, remodeling, and survival. embryonic lethal. The same is true for VEGF-Rs (Flk1 and Flt1) wtVEGF-/- but VEGF120+/+ have: normal embryonic vascular development widespread vessel patterning defect fewer branch points. larger luminal diameter. (Carmeliet 1999, Stalmans and Ng 2002) post-natal angiogenesis defects. (Shima group)

Reduced vascular branching with KO

Heparin binding reduces vessel complexity However, this defect is NOT cell proliferation. Instead, new endothelial cells are incorporated into nascent blood Vessels (which are subsequently bigger).

Greater VEGF dispersion when there is no heparin binding. Normally, there is a Steep concentration gradient Of VEGF Now, the VEGF Is more dispersed.

Mice expressing ONLY heparing-binding VEGF (188) have thinner vessels!!

Too much or too little heparin binding of VEGF is a problem However, double heterozygotes compensate for each other and are wt.

Various members of the VEGF/PDGF and bFGF are alternatively spliced proteolyzed. which regulate proteoglycan and ECM binding. Ref (Betsholtz, 2001, Eriksson and Alitalo 1999) (Sunny?) Are there other molecules that regulate VEGF/growth factors?

Fibronectin binds VEGF VEGF and FN induce migration. VEGF and FN do not induce Migration alone (Wijelath, …Rafii, Sobel, Circ Res)

VEGF/FN mediate alpha5beta/FLK-1 interaction Anti-a5b1 inhibits migration

FN contains 2 VEGF binding sites FN can be proteolyzed into fragments VEGF binds mainly FN Only the N- and C-terminal (not RGD) fragments bind VEGF

Model of VEGF/FN/Flk-1/a5b1 action Complex induces downstream signalling.

Any thoughts? How important is this microenvironment? (Not at cellular level, not at organismal level, but somewhere in between) How important is release? MMPs reveal cryptic binding sites. Proteases may release bioavailability.